Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Rectum”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00012246
What this trial is testing

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+4 more
The University of Texas Medical Branch, Galveston 7
Testing effectiveness (Phase 2)UnknownNCT05815303
What this trial is testing

XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer

Who this might be right for
Rectal CancerMSS
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 92
Testing effectiveness (Phase 2)Study completedNCT00645710
What this trial is testing

Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery

Who this might be right for
Liver MetastasesRecurrent Colon CancerRecurrent Rectal Cancer+2 more
City of Hope Medical Center 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07511023
What this trial is testing

Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum

Who this might be right for
Phase 2Sacituzumab TirumotecanRefractory Metastatic+2 more
M.D. Anderson Cancer Center 20
Not applicableUnknownNCT00819559
What this trial is testing

Preoperative Chemoradiotheray for Rectal Cancer

Who this might be right for
Rectal Neoplasm
Korean Rectal Cancer Study Group 1,160
Early research (Phase 1)Study completedNCT00052559
What this trial is testing

Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer

Who this might be right for
Adenocarcinoma of the RectumStage II Rectal CancerStage III Rectal Cancer
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Looking for participantsNCT07602842
What this trial is testing

IDP-001 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorHead and Neck Squamous Cell Carcinoma+6 more
InduPro, Inc. 132
Early research (Phase 1)Ended earlyNCT03300544
What this trial is testing

Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer

Who this might be right for
Locally Advanced Rectal AdenocarcinomaMetastatic Rectal AdenocarcinomaRectal Adenocarcinoma+7 more
National Cancer Institute (NCI) 3
Not applicableStudy completedNCT02810652
What this trial is testing

Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection

Who this might be right for
Pancreatic CancerEsophageal CancerGastric Cancer+3 more
Massachusetts General Hospital 160
Not applicableStudy completedNCT05959564
What this trial is testing

A Chatbot Intervention for Reducing HPV Vaccine Hesitancy

Who this might be right for
Cervical CancerAnal CancerPenile Cancer
University of Maryland, College Park 456
Testing effectiveness (Phase 2)Active Not RecruitingNCT07160647
What this trial is testing

The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)

Who this might be right for
dMMR/MSI-H-type Rectal Adenocarcinoma
Sir Run Run Shaw Hospital 29
Not applicableStudy completedNCT02728804
What this trial is testing

S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer

Who this might be right for
Stage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon Cancer+1 more
SWOG Cancer Research Network 380
Testing effectiveness (Phase 2)Active Not RecruitingNCT06640049
What this trial is testing

Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China

Who this might be right for
Neoplasms, Rectal
GlaxoSmithKline 23
Testing effectiveness (Phase 2)Study completedNCT00028626
What this trial is testing

Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00414232
What this trial is testing

Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy

Who this might be right for
Rectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 13
Testing effectiveness (Phase 2)Looking for participantsNCT05136326
What this trial is testing

Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer

Who this might be right for
Rectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 21
Not applicableStudy completedNCT06505863
What this trial is testing

Quality of Life After Transanal Total Mesorectal Excision Compared to Traditional Total Mesorectal Excision

Who this might be right for
Rectal CancerQuality of LifeFunctional Outcome+1 more
Cantonal Hospital of St. Gallen 249
Post-approval studies (Phase 4)Looking for participantsNCT07209787
What this trial is testing

SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak

Who this might be right for
Rectal Cancer
Beijing Chao Yang Hospital 966
Early research (Phase 1)Study completedNCT01634685
What this trial is testing

A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma

Who this might be right for
Rectal Adenocarcinoma
University of Texas Southwestern Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT00940316
What this trial is testing

Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Northwestern University 28
Next Page